Your browser doesn't support javascript.
loading
Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity.
Schramm, Franziska; Zur Stadt, Udo; Zimmermann, Martin; Jorch, Norbert; Pekrun, Arnulf; Borkhardt, Arndt; Imschweiler, Thomas; Christiansen, Holger; Faber, Jörg; Schmid, Irene; Feuchtinger, Tobias; Beron, Gerhard; den Boer, Monique L; Pieters, Rob; Horstmann, Martin A; Janka-Schaub, Gritta E; Escherich, Gabriele.
Afiliación
  • Schramm F; Clinic of Pediatric Hematology and Oncology, University Medical Centre, Hamburg-Eppendorf Hamburg, Germany.
  • Zur Stadt U; Clinic of Pediatric Hematology and Oncology, University Medical Centre, Hamburg-Eppendorf Hamburg, Germany.
  • Zimmermann M; Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany.
  • Jorch N; Department of Pediatric Hematology and Oncology, Hospital Bielefeld, Bielefeld, Germany.
  • Pekrun A; Department of Pediatric Hematology and Oncology, Hospital Bremen-Mitte, Bremen, Germany.
  • Borkhardt A; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty Duesseldorf, Duesseldorf, Germany.
  • Imschweiler T; Department of Pediatric Hematology and Oncology, Helios Hospital, Krefeld, Germany.
  • Christiansen H; Clinic of Pediatric Hematology and Oncology, University Medical Centre Leipzig, Leipzig, Germany.
  • Faber J; Department of Pediatric Hematology/Oncology, University Hospital Mainz, Mainz, Germany.
  • Schmid I; Dr. von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany.
  • Feuchtinger T; Dr. von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany.
  • Beron G; Department of Pediatric Hematology and Oncology, Helios Hospital, Wiesbaden, Germany.
  • den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; and.
  • Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; and.
  • Horstmann MA; Clinic of Pediatric Hematology and Oncology, University Medical Centre, Hamburg-Eppendorf Hamburg, Germany.
  • Janka-Schaub GE; Research Institute Children's Cancer Centre, Hamburg, Germany.
  • Escherich G; Clinic of Pediatric Hematology and Oncology, University Medical Centre, Hamburg-Eppendorf Hamburg, Germany.
Blood Adv ; 3(22): 3688-3699, 2019 11 26.
Article en En | MEDLINE | ID: mdl-31765480
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article